...
首页> 外文期刊>Cytotechnology >A hyman hybrid hybridoma producing a bispecific monoclonal antibody that can target tumor cells for attack by Pseudomonas aeruginosa exotoxin A
【24h】

A hyman hybrid hybridoma producing a bispecific monoclonal antibody that can target tumor cells for attack by Pseudomonas aeruginosa exotoxin A

机译:产生双特异性单克隆抗体的海曼杂交杂交瘤,该双特异性单克隆抗体可靶向肿瘤细胞,使其受到铜绿假单胞菌外毒素A的攻击

获取原文
           

摘要

By fusing a human hybridoma producing an IgG2? antibody against human A431 epidermoid carcinoma cells with an Epstein-Barr virus-transformed human B lymphocyte producing an IgG2? antibody against Pseudomonas aeruginosa exotoxin A, we established a hybrid hybridoma producing a bispecific monoclonal antibody reacting with both A431 cells and the exotoxin. Human IgG was purified from the culture supernatant of the hybrid hybridoma, and the bispecific monoclonal antibody in the IgG preparation was further separated from the two parental antibodies by hydroxyapatite high-performance liquid chromatography. The human bispecific monoclonal antibody thus obtained efficiently targeted the antibody-reative cells, A431, for attack by the exotoxin in vitro.
机译:通过融合产生IgG2α的人杂交瘤。抗人A431表皮样癌细胞的抗体,由EB病毒转化的人B淋巴细胞产生IgG2?针对铜绿假单胞菌外毒素A的抗体,我们建立了一种杂交瘤细胞,该杂交瘤产生与A431细胞和外毒素反应的双特异性单克隆抗体。从杂交杂交瘤的培养上清液中纯化人IgG,并通过羟基磷灰石高效液相色谱法将IgG制剂中的双特异性单克隆抗体与两种亲本抗体进一步分离。由此获得的人双特异性单克隆抗体有效地靶向抗体反应性细胞A431,使其在体外受到外毒素的攻击。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号